The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
2010
How MCT-1 and p53 Interact in Cancer
publication
Evidence: high
Author Information
Author(s): Kasiappan Ravi, Shih Hung-Ju, Wu Meng-Hsun, Choy ChikOn, Lin Tai-Du, Chen Linyi, Hsu Hsin-Ling
Primary Institution: National Health Research Institutes
Hypothesis
MCT-1 may counteract p53 through diverse mechanisms that determine tumorigenic outcomes.
Conclusion
MCT-1 oncogenicity can overcome p53 function, which persistently advances tumor development.
Supporting Evidence
- MCT-1 has been identified as a novel target gene of p53 transcriptional regulation.
- Functional p53 suppresses MCT-1 promoter activity and mRNA stability.
- MCT-1 decreases p53 promoter function and mRNA stability.
- MCT-1 promotes tumorigenicity in mice xenografts of p53-null and p53-positive lung cancer cells.
- The reactivation of p53 cannot restrain the tumorigenic impacts of MCT-1.
Takeaway
MCT-1 is a protein that helps cancer grow, and it can make a cancer-fighting protein called p53 less effective.
Methodology
The study involved in vitro and in vivo experiments, including luciferase assays, ChIP assays, and analysis of mRNA stability.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website